therxconnect.org
G - RXConnect
http://www.therxconnect.org/g.html
Simply click on any of the links below and you will automatically be sent to. The website that contains the coupon information. Some coupons are available to. Print right away and some are only available once you sign up for a particular. Program through the manufacturer. Once the coupon is printed, bring it into the. Pharmacy and enjoy the savings! Coupons are added and deleted often, so check. Certain coupons cannot be used if patient has Medicare Part D (prescription. Solutions Plus Enrollment Form.
giotrif.com
LUX-Lung 3 Clinical Trial | GIOTRIF® (afatinib)
https://www.giotrif.com/healthcare_professionals/first_line_efficacy_and_safety/pfs.html
Skip to main content. GIOTRIF (afatinib) as monotherapy is indicated for the treatment of: Epidermal Growth Factor Receptor (EGFR) TKI-naïve adult patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) with activating EGFR mutation(s); locally advanced or metastatic NSCLC of squamous histology progressing on or after platinum-based chemotherapy. For more information please see the EU Summary of Product Characteristics. See countries where GIOTRIF. 1st Line EGFR M. Demonstrated su...
giotrif.com
EGFR Mutations & Biomarker Testing | GIOTRIF® (afatinib)
https://www.giotrif.com/healthcare_professionals/egfr_testing/incidence.html
Skip to main content. GIOTRIF (afatinib) as monotherapy is indicated for the treatment of: Epidermal Growth Factor Receptor (EGFR) TKI-naïve adult patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) with activating EGFR mutation(s); locally advanced or metastatic NSCLC of squamous histology progressing on or after platinum-based chemotherapy. For more information please see the EU Summary of Product Characteristics. See countries where GIOTRIF. 1st Line EGFR M. Based on multip...
giotrif.com
EGFR Mutations & Biomarker Testing | GIOTRIF® (afatinib)
https://www.giotrif.com/healthcare_professionals/egfr_testing/Guidelines-on-Testing.html
Skip to main content. GIOTRIF (afatinib) as monotherapy is indicated for the treatment of: Epidermal Growth Factor Receptor (EGFR) TKI-naïve adult patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) with activating EGFR mutation(s); locally advanced or metastatic NSCLC of squamous histology progressing on or after platinum-based chemotherapy. For more information please see the EU Summary of Product Characteristics. See countries where GIOTRIF. 1st Line EGFR M. Based on multip...
giotrif.com
LUX-Lung 3 Clinical Trial | GIOTRIF® (afatinib)
https://www.giotrif.com/healthcare_professionals/first_line_efficacy_and_safety/os.html
Skip to main content. GIOTRIF (afatinib) as monotherapy is indicated for the treatment of: Epidermal Growth Factor Receptor (EGFR) TKI-naïve adult patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) with activating EGFR mutation(s); locally advanced or metastatic NSCLC of squamous histology progressing on or after platinum-based chemotherapy. For more information please see the EU Summary of Product Characteristics. See countries where GIOTRIF. 1st Line EGFR M. Demonstrated su...
kycancercare.com
Financial Assistance - Oncology Associates of Kentucky
http://www.kycancercare.com/financial-assistance
Cancer & Blood Disorders. There are many programs that we utilize to assist patients every day. Whether you are receiving a service in the outpatient setting, or needing prescription, there is most likely a foundation or financial assistance available for you. Below is a list of Foundations, Nonprofit Organizations, and Manufacturer Patient Assistance Programs that we commonly use. However, we occasionally may access programs not listed below. Foundations and Nonprofit Organizations. Eli Lilly and Company.
